(SMMT) Summit Therapeutics - Performance 153.1% in 12m
SMMT performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
54.74%
#6 in Peer-Group
Rel. Strength
96.34%
#273 in Stock-Universe
Total Return 12m
153.07%
#7 in Peer-Group
Total Return 5y
577.63%
#1 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 36.70 USD |
| 52 Week Low | 6.89 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 40.37 |
| Buy/Sell Signal +-5 | -1.23 |
| Support / Resistance | Levels |
|---|---|
| Support | 21.2, 18.9 |
| Resistance | 32.3, 30.0, 26.1 |
12m Total Return: SMMT (153.1%) vs XBI (-10.8%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
2.52% | 66.7% | 77.4% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-11.3% | -10.9% | 137% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-3.21% | -7.33% | 26.4% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
2.47% | 33.7% | 4.38% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
0.91% | -10.3% | 0.26% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.3% | 65.1% | -9.72% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
1.94% | 59.9% | -1.58% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.88% | 35.5% | 16% | 28.9 | 15.1 | 0.63 | -62.1% | -19.3% |
Performance Comparison: SMMT vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for SMMT
| Total Return (including Dividends) | SMMT | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -21.40% | 3.18% | 4.55% |
| 3 Months | 6.79% | 2.36% | 10.78% |
| 12 Months | 153.07% | -10.75% | 14.71% |
| 5 Years | 577.63% | -24.51% | 112.53% |
| Trend Score (consistency of price movement) | SMMT | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 52.1% | 18.8% | 79.2% |
| 3 Months | -10.7% | 71.5% | 92.9% |
| 12 Months | 58.2% | -84.3% | 44.2% |
| 5 Years | 29.4% | -52.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th8.50 | -23.82% | -24.81% |
| 3 Month | %th54.50 | 4.33% | -3.14% |
| 12 Month | %th96.50 | 183.56% | 121.67% |
| 5 Years | %th99.50 | 797.62% | 212.40% |
FAQs
Does Summit Therapeutics (SMMT) outperform the market?
Yes,
over the last 12 months SMMT made 153.07%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.75%.
Over the last 3 months SMMT made 6.79%, while XBI made 2.36%.
Performance Comparison SMMT vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
SMMT vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -1.9% | -26% | 9.1% | 138% |
| US NASDAQ 100 | QQQ | -2.1% | -26.9% | 8.6% | 139% |
| German DAX 40 | DAX | -2.3% | -21.8% | -5.2% | 122% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -1.6% | -25.6% | 11.1% | 135% |
| Hongkong Hang Seng | HSI | -1.5% | -27.2% | -6.6% | 118% |
| India NIFTY 50 | INDA | -1.5% | -23.5% | 9.4% | 153% |
| Brasil Bovespa | EWZ | -3.3% | -29.2% | -15.4% | 140% |
SMMT vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -2.6% | -28.3% | 3.7% | 125% |
| Consumer Discretionary | XLY | -0.9% | -23.3% | 18% | 133% |
| Consumer Staples | XLP | 2.1% | -20.2% | 11.1% | 144% |
| Energy | XLE | 1.9% | -25.9% | 12.6% | 156% |
| Financial | XLF | -1.2% | -23.9% | 6.8% | 125% |
| Health Care | XLV | -0.3% | -23.1% | 16.7% | 159% |
| Industrial | XLI | -1% | -24.6% | 3.2% | 130% |
| Materials | XLB | -0.1% | -23.7% | 9.2% | 150% |
| Real Estate | XLRE | 3.3% | -20.9% | 11.7% | 141% |
| Technology | XLK | -2.2% | -29.8% | 7.8% | 142% |
| Utilities | XLU | 0.9% | -22.4% | 6.3% | 129% |
| Aerospace & Defense | XAR | -3.3% | -31% | -11.1% | 101% |
| Biotech | XBI | 0.1% | -24.6% | 22.8% | 164% |
| Homebuilder | XHB | -0.1% | -25.3% | 20.5% | 152% |
| Retail | XRT | 0.8% | -23.5% | 17.4% | 147% |
SMMT vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 5.1% | -30.5% | 17.2% | 163% |
| Natural Gas | UNG | 2.8% | -24.8% | 23.4% | 153% |
| Gold | GLD | 3% | -19.2% | -10.8% | 112% |
| Silver | SLV | 2.1% | -29.1% | -8.3% | 132% |
| Copper | CPER | -2.2% | -25.6% | -10.6% | 138% |
SMMT vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 0.3% | -23.2% | 13.8% | 152% |
| iShares High Yield Corp. Bond | HYG | 0.2% | -23.3% | 10.1% | 142% |